key: cord-0826992-5cpg02ha authors: Pedro, N.; Silva, C. N.; Magalhaes, A. C.; Cavadas, B.; Rocha, A. M.; Moreira, A. C.; Gomes, S.; Silva, D.; Sobrinho-Simoes, J.; Ramos, A.; Cardoso, M. J.; Filipe, R.; Palma, P.; Ceia, F.; Silva, S.; Guimaraes, J. T.; Sarmento, A.; Fernandes, V.; Pereira, L.; Tavares, M. title: Dynamics of a dual SARS-CoV-2 strain co-infection on a prolonged viral shedding COVID-19 case: insights into clinical severity and disease duration date: 2020-12-23 journal: nan DOI: 10.1101/2020.12.22.20248392 sha: 2b88b49b724763fea3eeb2594ca087238b5635bd doc_id: 826992 cord_uid: 5cpg02ha Objectives. A few molecularly proven SARS-CoV-2 cases of symptomatic reinfection are currently known worldwide, with a resolved first infection followed by a second infection after a 48 to 142-day intervening period. We report a multiple-component study of a clinically severe and prolonged viral shedding COVID-19 case in a teenager Portuguese female. She had two hospitalisations, a total of 19 RT-PCR tests, mostly positive, and criteria for releasing from home isolation at the end of 97 days. Methods. The viral genome was sequenced in seven serial samples and in the diagnostic sample from an infected close relative. A human genome-wide array (>900K) was screened on the seven samples, and in vitro culture was conducted on isolates from three late samples. Results. The patient had co-infection by two SARS-CoV-2 strains, affiliated in distinct clades and diverging by six variants. The 20A lineage was absolute at the diagnosis (shared with a cohabitating relative), but nine days later the 20B lineage had 3% frequency, and two months later the 20B lineage had 100% frequency. The 900K profiles confirmed the identity of the patient in the serial samples, and allowed us to infer that she had polygenic risk scores for hospitalization and severe respiratory disease within the normal distributions for a Portuguese population cohort. Conclusions. The early-on dynamic co-infection was the probable cause for the severity of COVID-19 in this otherwise healthy young patient, and for her prolonged SARS-CoV-2 shedding profile. The new Coronavirus disease 2019 , caused by the severe acute respiratory 56 syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan, China [1] and rapidly 57 disseminated at a global scale. While the world is currently in the countdown for a vaccine, (3) or simply RT-PCR tests detecting viral remains and not necessarily active viral particles. 64 To untangle between the two first possibilities, it is necessary to perform viral whole-genome workers, whom were routinely screened in their workplace [11] . Although these two cases were 78 asymptomatic in the first and second infections, the viral load was higher in the second one, as is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint inferred from the RT-PCR cycle threshold. Another theoretical possibility is the occurrence of 80 reinfection while the first infection was not yet cured, a situation best described as co-infection. This hypothesis was advanced by the authors for the USA reinfection case [9], but not 82 thoroughly studied. In this work, we report the first molecularly proven dynamic early-on co-infection by two 84 genetically distinct SARS-CoV-2 strains. This was a prolonged viral shedding case (97-day 85 long), with a first severe disease manifestation, followed by a short-second hospitalisation 86 episode, in an otherwise healthy young female. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The serological test used was a chemiluminescent microparticle immunoassay for qualitative 101 detection of IgG against SARS-CoV-2 nucleoprotein (Abbott Diagnostics, Chicago, USA). Serum samples were run on the Abbott Architect instrument following the manufacturer's 103 instructions. The amount of IgG antibodies to SARS-CoV-2 in each sample was determined 104 by comparing its chemiluminescent relative light unit (RLU) to the calibrator RLU (index S/C). A signal/cut-off (S/CO) ratio of ≥1.4 was interpreted as reactive and an S/CO ratio of <1.4 was 106 interpreted as non-reactive. The research protocol was approved by the Ethics Committee of the CHUSJ and University of is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint not detected in the first culture. We included a recently-diagnosed sample from another patient 163 to guarantee the assay was able to detect the viral particles. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint Clinical features 168 A previously healthy young female presented to the local hospital emergency department in 169 the beginning of March reporting a 9-day history of sustained fever, dry cough, pleuritic chest 170 pain and vomiting. She was hemodynamically stable (105/63 mmHg blood pressure), but 171 tachypnoeic (28 cpm respiratory rate), hypoxic to 88% on room air and febrile to 101.3ºF. Her is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint The patient was asked to continue isolating at home until attaining two consecutive negative 192 tests. Nearly two months after discharge, she was re-admitted with headaches, fever, myalgia and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint viral particles from these samples through in vitro culture (Figure 2) , despite some of these 216 samples being still positive in the RT-PCR. 217 The sequencing of the viral genome in the serial samples from the patient revealed very 218 interesting results (Figure 1 and 3 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint Discussion 257 We illustrate a severe presentation of COVID-19 in a young healthy patient with prolonged 258 viral shedding of SARS-CoV-2. This case was extremely challenging in terms of clinical 259 diagnosis, and only the molecular study allowed us to shed light into its classification as the 260 first proven SARS-CoV-2 co-infection. The affiliation of the two haplotypes in distinct clades, which emerged at different time points is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint probably the close relative was only infected by one strain, hence displaying the milder disease, 281 although we could not test it due to the unavailability of samples. For sure, in the near future, several other cases of co-infection and reinfection will be identified 283 as the pandemic continues. These cases will help to clarify if a worse disease course can be is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted December 23, 2020. ; https://doi.org/10.1101/2020.12.22.20248392 doi: medRxiv preprint A Novel Coronavirus from Patients with Pneumonia 333 in China Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical 336 isolation observation Re-infection with SARS-CoV-2: What Goes Around May Come Back Around Is recurrence possible in coronavirus disease 2019 341 (COVID-19)? Case series and systematic review of literature What reinfections mean for COVID-19 347 COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole 348 genome sequencing Symptomatic SARS-CoV-2 reinfection 351 by a phylogenetically distinct strain COVID-19 re-infection by a phylogenetically distinct 354 SARS-CoV-2 variant, first confirmed event in South America Genomic evidence for reinfection with 357 SARS-CoV-2: a case study A perspective on potential antibody-dependent enhancement of SARS-CoV-2, 360 Asymptomatic reinfection in two 363 healthcare workers from India with genetically distinct SARS-CoV-2 366 The Sequence Alignment/Map format and SAMtools ViPR: an open bioinformatics 369 database and analysis resource for virology research MAFFT online service: multiple sequence alignment, 372 interactive sequence choice and visualization IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era Interactive Tree Of Life (iTOL) v4: recent updates and new developments PADRE: Pedigree-379 Aware Distant-Relationship Estimation The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of 381 host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic Data, disease and diplomacy: GISAID's innovative contribution to 384 global health SARS-CoV-2 exhibits 386 intra-host genomic plasticity and low-frequency polymorphic quasispecies Viral quasispecies evolution, Microbiol Nextstrain: real-time tracking of pathogen evolution Virological assessment of hospitalized patients with COVID-396 2019 Virus shedding dynamics in asymptomatic and mildly symptomatic 399 patients infected with SARS-CoV-2